Adverum Biotechnologies

Company Deals

Eli Lilly to Acquire Adverum Biotechnologies for Up to USD 261.7m for Ixo-vec Access

Fineline Cube Oct 27, 2025

Eli Lilly (NYSE: LLY) announced on October 24, 2025, that it will acquire gene therapy...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod